Mitchell S. Steiner
37Patents
11h-index
25Co-inventors
75Inventor score
Filing activity: Dec 5, 1997 → Apr 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6838484B2 | Formulations comprising selective androgen receptor modulators | Physics | 84 | Expired |
| US7026500B2 | Halogenated selective androgen receptor modulators and methods of use thereof | Chemistry; Metallurgy | 71 | Expired |
| US8008348B2 | Treating muscle wasting with selective androgen receptor modulators | Human Necessities | 31 | Active |
| US6899888B2 | Prevention and treatment of androgen-deprivation induced osteoporosis | Human Necessities | 30 | Expired |
| US7547728B2 | Treating muscle wasting with selective androgen receptor modulators | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6632447B1 | Method for chemoprevention of prostate cancer | Human Necessities | 26 | Expired |
| US7705182B2 | Multi-substituted selective androgen receptor modulators and methods of use thereof | Human Necessities | 23 | Active |
| US7855229B2 | Treating wasting disorders with selective androgen receptor modulators | Human Necessities | 18 | Active |
| US7803970B2 | Multi-substitued selective androgen receptor modulators and methods of use thereof | Human Necessities | 15 | Expired |
| US6413533B1 | Method for chemoprevention of prostate cancer | Human Necessities | 11 | Expired |
| US7776921B2 | Treating benign prostate hyperplasia with SARMS | Human Necessities | 11 | Expired |
| US6413535B1 | Method for chemoprevention of prostate cancer | Human Necessities | 10 | Expired |
| US6410043B1 | Method for chemoprevention of prostate cancer | Human Necessities | 9 | Expired |
| US6265448A | Method for chemoprevention of prostate cancer | Human Necessities | 6 | Expired |
| US9913815B2 | Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomiphene | Human Necessities | 5 | Active |
| US9427418B2 | Estrogen receptor ligands and methods of use thereof | Human Necessities | 4 | Active |
| US9624161B2 | Estrogen receptor ligands and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US8546451B2 | Estrogen receptor ligands and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US6413534B1 | Method for chemoprevention of prostate cancer | Human Necessities | 4 | Expired |
| US7595402B2 | Prodrugs of selective androgen receptor modulators and methods of use thereof | Chemistry; Metallurgy | 3 | Expired |
| US6177410A | Therapeutic methods for prostate cancer | Chemistry; Metallurgy | 2 | Expired |
| US10258596B2 | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) | Human Necessities | 2 | Active |
| US9051267B2 | Estrogen receptor ligands and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US9744149B2 | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) | Human Necessities | 2 | Active |
| US9969683B2 | Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.